A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer. [electronic resource]
Producer: 20021212Description: 239-47 p. digitalISSN:- 0030-2414
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cisplatin -- administration & dosage
- Docetaxel
- Dose-Response Relationship, Drug
- Female
- Fluorouracil -- administration & dosage
- Gastrointestinal Diseases -- chemically induced
- Hematologic Diseases -- chemically induced
- Humans
- Leucovorin -- administration & dosage
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neutropenia -- chemically induced
- Paclitaxel -- administration & dosage
- Stomach Neoplasms -- drug therapy
- Taxoids
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.